Chen Buze
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 2
-
- Ovarian cancer diagnosis and treatment 6
- Co-authors
- Xiaoyuan Lu (10 shared papers)Sicong Liu (4 shared papers)Jiangjun Wei (1 shared paper)Li Gong (1 shared paper)Xingyao Li (1 shared paper)Haihong Wang (5 shared papers)Haihong Wang (4 shared papers)Guilin Li (2 shared papers)
- Journals
- Recent Patents on Anti-Cancer Drug Discovery (1 paper)Journal of Ovarian Research (1 paper)Frontiers in Bioscience-Landmark (1 paper)Current Gene Therapy (1 paper)Physics of Fluids (1 paper)
- Partner nations
- China
In The Last Decade
Chen Buze
24 papers receiving 279 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 64
- Drug Discovery 1
- Fluid Flow and Transfer Processes 23
- Oncology 48
- Reproductive Medicine 19
Countries citing papers authored by Chen Buze
This map shows the geographic impact of Chen Buze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Buze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Buze more than expected).
Fields of papers citing papers by Chen Buze
This network shows the impact of papers produced by Chen Buze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Buze. The network helps show where Chen Buze may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Buze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 85 | |
| 2 | 2022 | 30 | |
| 3 | 2022 | 27 | |
| 4 | 2021 | 22 | |
| 5 | 2021 | 19 | |
| 6 | 2021 | 15 | |
| 7 | 2021 | 14 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 11 | |
| 10 | 2023 | 8 | |
| 11 | 2024 | 8 | |
| 12 | 2021 | 7 | |
| 13 | 2023 | 6 | |
| 14 | Expression of PKG2 in ovarian cancer and its effect on epidermal growth factor receptor. | 2021 | 5 |
| 15 | 2024 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2025 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 3 |
About Chen Buze
Chen Buze is a scholar working on Cancer Research, Reproductive Medicine, Obstetrics and Gynecology, Oncology and Computational Mechanics, having authored 26 papers that have together received 297 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), MicroRNA in disease regulation (5 papers), Endometrial and Cervical Cancer Treatments (3 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Fluid Dynamics and Turbulent Flows (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Heat transfer and supercritical fluids (2 papers). The work is most often cited by research in Cancer Research (64 citations), Drug Discovery (1 citation), Fluid Flow and Transfer Processes (23 citations), Oncology (48 citations) and Reproductive Medicine (19 citations). Chen Buze has collaborated with scholars based in China. Frequent co-authors include Xiaoyuan Lu, Sicong Liu, Jiangjun Wei, Li Gong, Xingyao Li, Haihong Wang, Haihong Wang, Guilin Li, Guilin Li and Jing Li. Their work appears in journals such as Recent Patents on Anti-Cancer Drug Discovery, Journal of Ovarian Research, Frontiers in Bioscience-Landmark, Current Gene Therapy and Physics of Fluids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.